- Public Comps
- Pro Medicus
Pro Medicus Valuation Multiples
Discover Pro Medicus' revenue and EBITDA valuation multiples and investment history, alongside public comparables like United Imaging, ICON plc, Revvity, Glaukos and more.
Pro Medicus Overview
About Pro Medicus
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
Founded
1983
HQ

Employees
132
Website
Financials (LTM)
EV
$13B
Valuation Multiples
Start free trialPro Medicus Financials
Pro Medicus reported last 12-month revenue of $196M and EBITDA of $159M.
In the same LTM period, Pro Medicus generated $196M in gross profit, $159M in EBITDA, and $109M in net income.
Revenue (LTM)
Pro Medicus P&L
In the most recent fiscal year, Pro Medicus reported revenue of $187M and EBITDA of $269M.
Pro Medicus is profitable as of last fiscal year, with gross margin of 100%, EBITDA margin of 144%, and net margin of 101%.
Financial data powered by Morningstar, Inc.
Pro Medicus Stock Performance
Pro Medicus has current market cap of $13B, and enterprise value of $13B.
Market Cap Evolution
Pro Medicus' stock price is $123.17.
Pro Medicus share price decreased by 4.2% in the last 30 days, and by 39.3% in the last year.
Pro Medicus has an EPS (earnings per share) of $1.81.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13B | $13B | -2.4% | -4.2% | -12.0% | -39.3% | $1.81 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPro Medicus Valuation Multiples
Pro Medicus trades at 64.8x EV/Revenue multiple, and 80.1x EV/EBITDA.
EV / Revenue (LTM)
Pro Medicus Financial Valuation Multiples
As of September 3, 2026, Pro Medicus has market cap of $13B and EV of $13B.
Pro Medicus has a P/E ratio of 117.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pro Medicus Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Pro Medicus Margins & Growth Rates
Pro Medicus grew revenue by 30% but EBITDA decreased by 29% in the last fiscal year.
In the most recent fiscal year, Pro Medicus reported gross margin of 100%, EBITDA margin of 144%, and net margin of 101%.
Pro Medicus Margins
Pro Medicus Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Pro Medicus Operational KPIs
Pro Medicus' revenue per employee in the last FY averaged $1.4M, while opex per employee averaged $0.4M for the same period.
Pro Medicus' Rule of 40 is 135% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pro Medicus' Rule of X is 176% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Pro Medicus Competitors
Pro Medicus competitors include United Imaging, ICON plc, Revvity, Glaukos, bioMérieux, Qiagen, M3 Inc., Sonic Healthcare, Lantheus Holdings and Exact Sciences.
Most Pro Medicus public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, HealthTech and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.7x | 5.1x | 32.0x | 28.2x | |||
| 1.8x | 1.8x | 18.2x | 10.7x | |||
| 5.9x | 5.9x | 23.0x | 19.1x | |||
| 20.5x | 16.5x | (66.4x) | 204.0x | |||
| 2.1x | 2.1x | 10.2x | 8.7x | |||
| 4.8x | 4.7x | 15.3x | 12.8x | |||
| 3.1x | 2.9x | 14.7x | 11.3x | |||
| 1.5x | 1.3x | 8.5x | 7.5x | |||
This data is available for Pro users. Sign up to see all Pro Medicus competitors and their valuation data. Start Free Trial | ||||||
Investments by Pro Medicus
Pro Medicus has invested in 1 company to date.
Latest investment by Pro Medicus was on August 17th 2026. Pro Medicus invested in Echo IQ in their Undisclosed stage round.
Latest Investments by Pro Medicus
| Description | Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care. |
| HQ Country | |
| HQ City | - |
| Deal Date | 17 Aug 2026 |
| Round | Undisclosed stage |
| Raised | undisclosed |
| Investors | Pro Medicus |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Pro Medicus investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pro Medicus
| When was Pro Medicus founded? | Pro Medicus was founded in 1983. |
| Where is Pro Medicus headquartered? | Pro Medicus is headquartered in Australia. |
| How many employees does Pro Medicus have? | As of today, Pro Medicus has over 132 employees. |
| Who is the CEO of Pro Medicus? | Pro Medicus' CEO is Sam Aaron Hupert. |
| Is Pro Medicus publicly listed? | Yes, Pro Medicus is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Pro Medicus? | Pro Medicus trades under PME ticker. |
| When did Pro Medicus go public? | Pro Medicus went public in 2000. |
| Who are competitors of Pro Medicus? | Pro Medicus main competitors include United Imaging, ICON plc, Revvity, Glaukos, bioMérieux, Qiagen, M3 Inc., Sonic Healthcare, Lantheus Holdings, Exact Sciences. |
| What is the current market cap of Pro Medicus? | Pro Medicus' current market cap is $13B. |
| What is the current revenue of Pro Medicus? | Pro Medicus' last 12 months revenue is $196M. |
| What is the current revenue growth of Pro Medicus? | Pro Medicus revenue growth (NTM/LTM) is 29%. |
| What is the current EV/Revenue multiple of Pro Medicus? | Current revenue multiple of Pro Medicus is 64.8x. |
| What is the current EBITDA of Pro Medicus? | Pro Medicus' last 12 months EBITDA is $159M. |
| What is Pro Medicus' EBITDA margin? | Pro Medicus' last 12 months EBITDA margin is 81%. |
| What is the current EV/EBITDA multiple of Pro Medicus? | Current EBITDA multiple of Pro Medicus is 80.1x. |
| What is the current FCF of Pro Medicus? | Pro Medicus' last 12 months FCF is $96M. |
| What is Pro Medicus' FCF margin? | Pro Medicus' last 12 months FCF margin is 49%. |
| What is the current EV/FCF multiple of Pro Medicus? | Current FCF multiple of Pro Medicus is 132.0x. |
| How many companies Pro Medicus has acquired to date? | Pro Medicus hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Pro Medicus has invested to date? | As of September 2026, Pro Medicus has invested in 1 company. |
| What was the last Pro Medicus investment? | On 17th August 2026 Pro Medicus invested in Echo IQ, participating in a Undisclosed stage round. |
| In what companies Pro Medicus invested in? | Pro Medicus invested in Echo IQ. |
See public comps similar to Pro Medicus
Lists including Pro Medicus
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





